All Cardioxyl articles
-
Business
Bristol-Myers Squibb to buy Cardioxyl for heart drug
Deal worth up to $2bn gives BMS full rights to Phase II clinical candidate
2015-11-03T00:00:00Z
Deal worth up to $2bn gives BMS full rights to Phase II clinical candidate
Site powered by Webvision Cloud